Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.380
+0.035 (1.05%)
At close: May 30, 2025, 4:00 PM
3.370
-0.010 (-0.30%)
After-hours: May 30, 2025, 7:53 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Lipocine stock ranges from a low of $8.00 to a high of $10. The average analyst price target of $9.00 forecasts a 166.27% increase in the stock price over the next year.
Price Target: $9.00 (+166.27%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lipocine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +136.69% | May 29, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +195.86% | Sep 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $33 | Buy | Reiterates | $33 | +876.33% | Jul 27, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $60 | Strong Buy | Maintains | $43 → $60 | +1,660.36% | Aug 26, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $51 | Buy | Initiates | $51 | +1,408.88% | Jun 24, 2021 |
Financial Forecast
Revenue This Year
1.53M
from 11.20M
Decreased by -86.30%
Revenue Next Year
1.04M
from 1.53M
Decreased by -32.20%
EPS This Year
-1.89
from -0.00
EPS Next Year
-1.48
from -1.89
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 1.1M | 1.3M | ||
| Avg | 1.5M | 1.0M | 1.2M | ||
| Low | 1.5M | 999,600 | 1.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -85.9% | -30.2% | 21.2% | ||
| Avg | -86.3% | -32.2% | 17.7% | ||
| Low | -86.8% | -34.8% | 13.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.94 | -1.52 | -1.16 |
| Avg | -1.89 | -1.48 | -1.12 |
| Low | -1.81 | -1.42 | -1.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.